A new immunotherapeutic agent for children and adolescents with advanced lymphoma
- OPACC
- Jun 8, 2020
- 1 min read
It establishes a new standard treatment with an improved cure rate for children with advanced non-Hodgkin lymphoma, mainly Burkitt lymphoma.
Comments